Oct 15, 2025 09:15AM Artelo Biosciences presents clinical data for two drug candidates

Sep 10, 2025 08:32AM Artelo Biosciences publishes preclinical data on ART12.11 compound

Sep 8, 2025 07:05AM D. Boral Capital Downgrades Artelo Biosciences, Inc. (ARTL) to Hold

Aug 25, 2025 07:55AM Artelo Biosciences reports positive food effect data for pain drug

Aug 13, 2025 06:55PM Artelo Biosciences, Inc. (ARTL) Misses Q2 EPS by 548c

Aug 4, 2025 08:07AM D. Boral Capital Reiterates Buy Rating on Artelo Biosciences, Inc. (ARTL)

Jul 9, 2025 07:50AM Artelo Biosciences reports osteoarthritis pain relief data for ART26.12

Jul 8, 2025 07:07AM D. Boral Capital Upgrades Artelo (ARTL) to Buy, 'Reverse Complete'

Jul 7, 2025 07:45AM Artelo presents preclinical data on depression drug candidate ART12.11

Jun 30, 2025 07:45AM Artelo Biosciences (ARTL) Announces Positive First-in-Human Data for ART26.12

Jun 26, 2025 08:02AM Artelo Biosciences (ARTL) Announces $1.425M ATM

Jun 11, 2025 09:57AM D. Boral Capital Downgrades Artelo Biosciences (ARTL) to Hold

Jun 11, 2025 08:30AM Artelo Biosciences (ARTL) Announces 1:6 Reverse Share Split

Jun 5, 2025 09:01AM Artelo's (ARTL) ART26.12 Compares Favorably to Naproxen in an Osteoarthritis Pain Study

May 13, 2025 05:23PM Artelo Biosciences, Inc. (ARTL) Misses Q1 EPS by 59c

Feb 14, 2025 09:00AM Artelo Biosciences (ARTL) Announces New Data on ART12.11 Tablets

Dec 9, 2024 09:15AM Artelo Biosciences (ARTL) Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia

Nov 12, 2024 04:50PM Artelo Biosciences, Inc. (ARTL) Tops Q3 EPS by 44c

Oct 1, 2024 07:15AM EF Hutton Starts Artelo (ARTL) at Buy

Aug 13, 2024 10:29AM Artelo Biosciences, Inc. (ARTL) Tops Q2 EPS by 4c

Jul 15, 2024 08:31AM Artelo Biosciences (ARTL) Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor